NCT02423720

Brief Summary

This is a audio based mindfulness meditation intervention for colorectal cancer patients and caregivers. A 8-week single arm study will be conducted among University of California, San Francisco (UCSF) patients with metastatic colorectal cancer undergoing chemotherapy and caregivers of these patients (44 participants total).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable colorectal-cancer

Timeline
Completed

Started Apr 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 22, 2015

Completed
6 days until next milestone

Study Start

First participant enrolled

April 28, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 3, 2016

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

February 23, 2018

Status Verified

February 1, 2018

Enrollment Period

1 year

First QC Date

April 17, 2015

Last Update Submit

February 22, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Proportion of eligible patients and caregivers who agree to be screened, consent to participate, and complete or partially complete the intervention, as a measure of feasibility and acceptability.

    8 weeks

  • Adherence to the intervention, as assessed by frequency and duration of practicing the exercises (recorded in a log and responses to text messages)

    8 weeks

Secondary Outcomes (4)

  • Reasons for ineligibility, as a measure of feasibility

    8 weeks

  • Proportion of enrolled patients and caregivers who refuse to participate in or complete the intervention, as a measure of feasibility and acceptability

    8 weeks

  • Reasons for non-participation/non-continuation of the intervention, as a measure of feasibility and acceptability

    8 weeks

  • Adherence to the intervention, as assessed by frequency and duration of practicing the exercises (recorded in a log and responses to text messages)

    8 weeks

Other Outcomes (6)

  • Quality of life, as assessed by NIH PROMIS instruments at the beginning, midpoint and end of the study

    0, 4 and 8 weeks

  • Distress, as assessed by NCCN Distress Thermometer and NIH PROMIS instruments at the beginning, midpoint and end of the study

    0, 4 and 8 weeks

  • Anxiety, as assessed by NCCN Distress Thermometer and NIH PROMIS instruments at the beginning, midpoint and end of the study

    0, 4 and 8 weeks

  • +3 more other outcomes

Study Arms (1)

Study Intervention

OTHER

Audio-based mindfulness intervention A 8-week single arm pilot study will be conducted among Helen Diller Famiily Comprehensive Cancer Center (HDFCCC) patients with metastatic colorectal cancer receiving chemotherapy and their caregivers (44 participants, total). Participants will receive an informational booklet containing a practice log and an MP3 player containing an introductory lecture and guided meditations. Practice reminders will be sent via text messages. Weekly emails will contain practice instructions and links to validated questionnaires.

Behavioral: Audio-Based Mindfulness

Interventions

Audio-based mindfulness tracks (MP3 format).

Study Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Eligible patients must:
  • Carry a diagnosis of metastatic colon, rectum, or small bowel adenocarcinoma
  • Anticipate receiving chemotherapy for at least 12 weeks total from the time of recruitment
  • Have life expectancy of at least 6 months
  • Have Karnofsky Performance Status ≥60
  • Be able to speak and read English
  • Have access to a mobile phone
  • Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet
  • Have a distress level of ≥3 on the NCCN Distress Thermometer (DT).\[1, 40\]
  • An effort will always be made to recruit patient and caregiver pairs, but unpaired patients are also eligible
  • Eligible caregivers are a spouse/partner, other family member, or a close friend of a patient with metastatic colon, rectum, or small bowel adenocarcinoma.
  • Eligible caregivers must:
  • Be able to speak and read English
  • Have access to a mobile phone
  • Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet

You may not qualify if:

  • This study is limited the study to patients with metastatic colon, rectum, or small bowel adenocarcinoma, because treatment regimens and disease trajectories for these disease groups are similar.
  • Patients with a DT level \>7 will be considered on a case-by- case basis. Patients and caregivers who participate in a focus group and meet criteria for the intervention will be given the opportunity to participate: data will be collected, but these patients/participants will not be included in the final analyses so as not to bias the results.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California San Francisco

San Francisco, California, 94158, United States

Location

Related Publications (1)

  • Atreya CE, Kubo A, Borno HT, Rosenthal B, Campanella M, Rettger JP, Joseph G, Allen IE, Venook AP, Altschuler A, Dhruva A. Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers. PLoS One. 2018 Jul 23;13(7):e0199423. doi: 10.1371/journal.pone.0199423. eCollection 2018.

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Chloe Atreya, MD, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2015

First Posted

April 22, 2015

Study Start

April 28, 2015

Primary Completion

May 3, 2016

Study Completion

January 1, 2017

Last Updated

February 23, 2018

Record last verified: 2018-02

Locations